OpGen, Inc. Profile Avatar - Palmy Investing

OpGen, Inc.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for t…

Medical - Diagnostics & Research
US, Rockville [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of OPGN's Analysis
CIK: 1293818 CUSIP: 68373L307 ISIN: US68373L4068 LEI: - UEI: -
Secondary Listings
OPGN has no secondary listings inside our databases.